The global non-Hodgkin’s lymphoma treatment market was valued at USD 13.44 Billion in 2024 and is projected to grow at a CAGR of 7.20% from 2025 to 2034, reaching USD 26.94 Billion by 2034. Growth is driven by technological advancements and increased availability of treatment options. The report highlights key market trends, drivers, and regional insights. https://www.expertmarketresearch.com/reports/non-hodgkins-lymphoma-treatment-market